Among postmenopausal AA women, IL1RN-rs4251961 was inversely associated with breast cancer risk, with CT/CC genotypes associated with a decreased risk (OR=0.65, 95% CI, 0.42-1.01). Here, IL1RN is linked to breast cancer.